Lokelma 5 g powder for oral suspension | medicines.ie

Company: AstraZeneca Pharmaceuticals (Ireland) DAC
Active Ingredient: Sodium Zirconium Cyclosilicate
Dosage Form: Powder for Oral Suspension
Legal Category: B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/17/1173/001	5 g	V03AE10	Powder for Oral Suspension
EU/1/17/1173/002	5 g	V03AE10	Powder for Oral Suspension
EU/1/17/1173/007	5 g	V03AE10	Powder for Oral Suspension
EU/1/17/1173/009	5 g	V03AE10	Powder for Oral Suspension

Licence number: EU/1/17/1173/001
Strength: 5 g
ATC Code: V03AE10
Dosage Form: Powder for Oral Suspension

Licence number: EU/1/17/1173/002
Strength: 5 g
ATC Code: V03AE10
Dosage Form: Powder for Oral Suspension

Licence number: EU/1/17/1173/007
Strength: 5 g
ATC Code: V03AE10
Dosage Form: Powder for Oral Suspension

Licence number: EU/1/17/1173/009
Strength: 5 g
ATC Code: V03AE10
Dosage Form: Powder for Oral Suspension

AstraZeneca Pharmaceuticals (Ireland) DAC

College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925, D15 R925 Dublin

Website: https://contactazmedical.astrazeneca.com
Telephone: +35316097100
Email: mipqc.ireland@astrazeneca.com